Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial

Autor: Arjona Ferreira, Juan C., Corry, Dalila, Mogensen, Carl E., Sloan, Lance, Xu, Lei, Golm, Gregory T., Gonzalez, Edward J., Davies, Michael J., Kaufman, Keith D., Goldstein, Barry J.
Zdroj: In American Journal of Kidney Diseases April 2013 61(4):579-587
Databáze: ScienceDirect